Systemic administration of NAC as an adjunct in the treatment of bioterror exposures such as smallpox and use in combination with DHEA for the treatment of smallpox
US 8,114,913 Lapsed on the fee recordLapsed Feb 14, 2020 on the fee record · From the USPTO record
20-year base term ended Nov 7, 2022
Second maintenance fee unpaid; grace period ended.
Nov 7, 2002
Feb 14, 2020
Feb 14, 2012
Nov 25, 2022
How we calculated this date
| Step | Input | Date after this step | Confidence |
|---|---|---|---|
| Base term, 20 years from filing | Clock starts Nov 7, 2002, when the earliest non-provisional application in its chain was filed (this one was filed Jun 18, 2009); a parent in its chain could not be resolved (the next row) | Nov 7, 2022 | From the USPTO record |
| Continuity chain | A parent in the chain could not be resolved | dated from this application's own claim | From the USPTO record |
| Patent term adjustment | +18 days, USPTO patent term adjustment record | Nov 25, 2022 | From the USPTO record |
| Terminal disclaimer cap | None on record | no cap applied | From the USPTO record |
| Patent term extension | None on file | no change | From the USPTO record |
| Fee events | 1 of 2 maintenance fees paid | lapsed Feb 14, 2020 | From the USPTO record |
| Computed term end | The steps above, in order | Feb 14, 2020 | From the USPTO record |
Sources
Google Patents · The patent document at USPTO · Assignment records at USPTO
USPTO account required: This application in Patent Center · USPTO's maintenance fee lookup
Maintenance fee events come from USPTO's own fee records. Its fee lookup asks for the patent number and the application number.
Not on this page: the patent's family, its recorded assignments and its citation count. USPTO's assignment records, linked above, list every recorded assignment.
Every date shows its work: the base term, any term adjustment or extension, any disclaimer cap, and the maintenance fee record, each with a confidence tier. How this record was built
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.